Clinical Trial Update: Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing teicoplanin and vancomycin as initial empirical antibiotics in febrile neutropenic patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia

Drugs mentioned

• Targocid (teicoplanin)
• Vancomycin (vancomycin)

Snippet

Sponsor: Sanofi | Conditions: Infection, Febrile Neutropenia | Phase 4 | Status: COMPLETED